Clinical Pathways in Neuro-ophthalmology : An ... - E-Lib FK UWKS

More documents

Recommendations

Info

58 Clinical Pathways in Neuro-Ophthalmology, second edition Meenken C, van den Horn GJ, de Smer MD, van der Meer JTM. (1998). Optic neuritis heralding varicella zoster virus retinitis in a patient with acquired immunodeficiency syndrome. Ann Neurol 43:534–536 Menon V, Tandon R, Khanna S, et al. (2000). Cysticercosis of the optic nerve. J Neuro-ophthalmol 20:59–60. Menon V, Tandon R, Sharma T, Gupta A. (1997). Optic neuritis following snake bite. Indian J Ophthalmol 45:236–237. Merandi SF, Kudryk BT, Murtagh FR, Arrington JA. (1991). Contrast-enhanced MR imaging of optic nerve lesions in patients with acute optic neuritis. AJNR 12:923–926. Merle D, Smadja D, Bera O, et al. (1997). Uveitis and papillitis in association with HTLV-I associated myelopathy. Ann Ophthalmol 29:258–261. Miller NR. (1995). Walsh and Hoyt’s Clinical Neuro-ophthalmology. 4th ed., vol. 5, pt 1. Baltimore, Williams and Wilkins, pp. 2895–2896. Miyashita K, Kigasawa K, Mashima Y, Fujino T. (1993). Superior altitudinal hemianopia and herpes zoster. Ann Ophthalmol 25:20–23. Moorman CM, Anslow P, Elston JS. (1999). Is sphenoid sinus opacity significant in patients with optic neuritis. Eye 13:76–82. Mori T, Terai T, Hatano M, et al. (1997). Stellate ganglion block improved loss of visual acuity caused by retrobulbar optic neuritis after herpes zoster. Anesth Analg 85:870–871. Morrissey SP, Miller DH, Kendall BE, et al. (1993). The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 116:135–146. Moschos M. (1990). Acute bilateral optic neuritis. Doc Ophthalmol 73:225–230. Nadkarni N, Lisak RP. (1993). Guillain-Barré syndrome (GBS) with bilateral optic neuritis and central white matter disease. Neurology 43:842–843. Nakazawa T, Abe T, Ohmura M. (1999). Varicella zoster-associated optic neuropathy with choroidal involvement. Neuro-ophthalmology 21:39–45. Newman NJ, Lessell S. (1992). Bilateral optic neuropathies with remission in two HIV-positive men. J Clin Neuro-ophthalmol 12:1–5. Newman NJ, Lessell S, Winterkorn JS. (1991). Optic chiasmal neuritis. Neurology 41:1203–1210. Nichols JW, Goodwin JA. (1992). Neuro-ophthalmologic complications of AIDS. Semin Ophthalmol 7:24–29. Ninomiya M, Ohashi K, Sasaki N, et al. (1990). A case of optic neuritis accompanying systemic lupus erythematosus several years after onset. Folia Ophthalmol Jpn 41:636. Noseworthy JH, O’Brien PC, Petterson TM, et al. (2001). A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology 56:1514–1522. Ohnuma I, Yamaguchi K, Takahashi S. (1996). Retrobulbar neuritis in a patient with mixed connective tissue disease. Folia Ophthalmol Jpn 47:828–831. Optic Neuritis Study Group. (1991). The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 109:1673–1678. Optic Neuritis Study Group. (1997a). The 5-year risk of MS after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Neurology 49:1404–1413. Optic Neuritis Study Group. (1997b). Visual function 5 years after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 115:1545–1552 O’Riordan JI, Gallagher HL, Thompson AJ, et al. (1996). Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatry 60:382–387. Patel SS, Rutzen AR, Marx JL, et al. (1996). Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome: visual prognosis of patients treated ganciclovir and foscarnet. Ophthalmology 103:1476–1482. Paty DW, Li DKB, the UBC MS=MRI Study Group, et al. (1993). Interferon beta-1b is effective in relapsingremitting multiple sclerosis, II: MRI analysis results of a multicenter, randomized, double-blind, placebocontrolled trial. Neurology 43:662–667. Paty DW, Oger JJF, Kastrukoff LF, et al. (1988). MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology 38:180–185. Percy AK, Norbrega FT, Kurland LT. (1992). Optic neuritis and multiple sclerosis. Arch Ophthalmol 87: 135–139. Perry JD, Girkin CA, Miller NR, Mann RB. (1999). Disseminated histoplasmosis causing reversible gaze palsy and optic neuropathy. J Neuro-ophthalmology 19:140–143. Phillips PH, Newman NJ, Lynn MJ. (1998). Optic neuritis in African Americans. Arch Neurol 55:186–192. Piccolo G, Franciotta DM, Camana C, et al. (1990). Devic’s neuromyelitis optica: long-term follow-up and serial CSF findings in two cases. J Neurol 237:262–264.
Optic Neuritis 59 Pierce EA, D’Amico DJ. (1993). Ocular toxoplasmosis: pathogenesis, diagnosis, and management. Semin Ophthalmol 8:40–52. Quicenco JI, Capparelli E, Sadun AA, et al. (1992). Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 113:8–13. Ramelli GP, Deonna T, Roulet E, et al. (1992). Transverse myelitis and optic neuromyelitis in children: apropos of 3 case reports. Schweiz Rundsch Med Prax 81:661–663. Rawson MD, Liversedge LA, Goldfarb G. (1966). Treatment of acute retrobuibar neuritis with corticotrophin. Lancet 2:1044–1046. Riedel P, Wall M, Grey A, et al. (1998). Autoimmune optic neuropathy. Arch Neurol 116:1121–1124. Rinalduzzi S, Brusa A, Jones SJ. (2001). Variation of visual evoked potential delay to stimulation of central, nasal, and temporal regions of the macula in optic neuritis. J Neurol Neurosurg Psychiatry 70:28–35. Rizzo JF, Lessell S. (1988). Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long term prospective study. Neurology 38:185–190. Roarty JD, Fisher EJ, Nussbaum JJ. (1993). Long-term morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 100:1685–1688. Rodriguez M, Siva A, Cross SA, et al. (1995). Optic neuritis: a population based study in Olmsted County, Minnesota. Neurology 45:244–250. Ropper AH, Wijdicks EFM, Truax BT. (1991). Guillain-Barré Syndrome. Philadelphia, FA Davis. Rose AS, Kuzma JW, Kurtzke JF, et al. (1970). Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo—final report. Neurology 20:1–59. Rose GE. (1991). Papillitis, retinal neovascularization and recurrent retinal vein occlusion in Toxoplasma retinochoroiditis: a case report with uncommon clinical signs. Aust NZ J Ophthalmol 19:155–157. Rosenbaum JT, Simpson J, Neuwelt CM. (1997). Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide. Br J Ophthalmol 81:130–132. Sadun AA, Pepose JS, Madigan MC, et al. (1995). AIDS-related optic neuropathy: a histological, virological and ultrastructural study. Graefes Arch Clin Exp Ophthalmol 233:387–398. Sakuma R, Fujihara K, Sato N, et al. (1999). Optic-spinal form of multiple sclerosis and anti-thyroid autoantibodies. J Neurol 246:449–453. Salzman MB, Sood SK, Slavin ML, et al. (1992). Ocular manifestations of Mycoplasma pneumoniae infection. Clin Infect Dis 14:1137–1139. Sandberg-Wollheim M. (1975). Optic neuritis: studies on the cerebrospinal fluid in relation to clinical course in 61 patients. Acta Neurol Scand 52:167–178. Sandberg-Wollheim M, Bynke H, Cronqvist S, et al. (1990). A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 27:386–393. Schneck ME, Haegerstrom-Portnoy G. (1997). Color vision defect type and spatial vision in the Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci 38:2278–2289. Schwartzman WA, Patnaik M, Angula FJ, et al. (1995). Bartonella (Rochalimaea) antibodies, dementia, and cat ownership among men infected with immunodeficiency virus. Clin Infect Dis 21:954–959. Schwartzman WA, Patnaik M, Barka NE, et al. (1994). Rochalimara antibodies in HIV associated neurologic disease. Neurology 44:1312–1316. Sedwick LA. (1991). Optic neuritis. Neurol Clin 9:97–112. Sellebjerg F, Christiansen M, Jensen J, Frederiksen JL. (2000). Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis. Eur J Neurol 7:281–289. Sellebjerg FT, Frederkisen JT. Olsson T. (1994). Anti-myelin basic protein and anti-proteolipid protein antibodysecreting cells in the cerebrospinal fluid of patients with acute optic neuritis. Arch Neurol 51:1032–1036. Sellebjerg F, Madsen HO, Frederiksen JL, et al. (1995). Acute optic neuritis: myelin basic protein and proteolipid protein antibodies, affinity and the HLA system. Ann Neurol 38:943–950. Sellebjerg F, Nielsen S, Frederiksen JL, Olesen J. (1999). A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis. Neurology 52:1479–1484. Shayegani A, Odel JG, Kazim M, et al. (1996). Varicella-zoster virus retrobulbar optic neuritis in a patient with human immunodeficiency virus. Am J Ophthalmol 112:586–588. Sheth RD, Goulden KJ, Pryse-Phillips WE. (1993). The focal encephalopathies associated with Mycoplasma pneumoniae. Can J Neurol Sci 20:319–323. Silber MH, Willcox PA, Bowen RM, et al. (1990). Neuromyelitis optica (Devic’s disease) and pulmonary tuberculosis. Neurology 40:934–938. Silberberg DH. (1993). Corticosteroids and optic neuritis. N Engl J Med 329:1808–1810.
Page 2 and 3:
This page intentionally left blank
Page 4 and 5:
Page 6 and 7:
Thieme New York 333 Seventh Avenue
Page 8 and 9:
To our wives, Hilary and Liz and to
Page 10 and 11:
Page 12 and 13:
x Preface We would again like to th
Page 14 and 15:
2 Clinical Pathways in Neuro-Ophtha
Page 16 and 17:
Page 18 and 19:
Page 20 and 21: 8 Clinical Pathways in Neuro-Ophtha
Page 22 and 23: 10 Clinical Pathways in Neuro-Ophth
Page 30 and 31: Table 1-12. Clinical Features of Ra
Page 74 and 75: This page intentionally left blank
Page 112 and 113: 100 Clinical Pathways in Neuro-Opht
Page 120 and 121:
108 Clinical Pathways in Neuro-Opht
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
13 r Sixth Nerve Palsies What is th
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Page 338 and 339:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 380 and 381:
Page 382 and 383:
Page 384 and 385:
Page 386 and 387:
Page 388 and 389:
Page 390 and 391:
Page 392 and 393:
Page 394 and 395:
Page 396 and 397:
Page 398 and 399:
Page 400 and 401:
Page 402 and 403:
Page 404 and 405:
Page 406 and 407:
Page 408 and 409:
Page 410 and 411:
Page 412 and 413:
Page 414 and 415:
Page 416 and 417:
Page 418 and 419:
Page 420 and 421:
Page 422 and 423:
Page 424 and 425:
Page 426 and 427:
Page 428 and 429:
Page 430 and 431:
Page 432 and 433:
Page 434 and 435:
Page 436 and 437:
Page 438 and 439:
Page 440 and 441:
Page 442 and 443:
Page 444 and 445:
Page 446 and 447:
Page 448 and 449:
Page 450 and 451:
Page 452 and 453:
Page 454 and 455:
Page 456 and 457:
Page 458 and 459:
Page 460 and 461:
Page 462 and 463:
Page 464 and 465:
Page 466 and 467:
Page 468 and 469:
Page 470 and 471:
Page 472 and 473:
Page 474 and 475:
Page 476 and 477:
Index r Page numbers in italic indi
Page 478 and 479:
Page 480 and 481:
Page 482 and 483:
Page 484 and 485:
Page 486 and 487:
Page 488 and 489:
Page 490 and 491:
Page 492 and 493:
Page 494 and 495:
Page 496 and 497:
Page 498:
show all

Clinical Pathways in Neuro-ophthalmology : An ... - E-Lib FK UWKS

Create successful ePaper yourself

Delete template?

Save as template?